Cognitive, Emotional, and Behavioral Disorders in Children with Respiratory Allergic Diseases: Causes and Solutions

The publication is devoted to the review of accumulated data on the relationship of respiratory allergopathology with neuropsychiatric disorders in childhood. The immediacy of the problem is due to the mutual influence of allergic and neuropsychiatric conditions combined in a child on the course of these diseases. According to research, the connection of respiratory allergic diseases with disorders of neurodevelopment, in particular with attention deficit and hyperactivity disorder and autism spectrum disorders, is clearly manifested, and the first publications on the connection with speech and other mild cognitive impairments have appeared. At the same time, the formation of depression, suicidal behavior, and anxiety disorders in respiratory allergopathology is being actively studied. It is assumed that the close relationship between nervous and immune regulation provides a high correlation of allergic and neuropsychiatric pathological conditions, although cause-and-effect relationships have not yet been precisely established. In this regard, it becomes relevant to introduce into clinical practice monitoring of cognitive status, neuropsychic development and possible symptoms of anxiety, depression and suicidal thoughts in the treatment of children with respiratory allergic diseases. Timely detection of violations will make it possible to provide specialized interventions at an early stage in order to achieve a favorable treatment result in the long term.

1. Baena-Cagnani CE. The global burden of asthma and allergic diseases: the challenge for the new century. Curr Allergy Asthma Rep. 2001l;1(4):297–298. https://doi.org/10.1007/s11882-001-0037-z

2. Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy. 2004;34(4):520–526. https://doi.org/10.1111/j.1365-2222.2004.1935.x

3. Soloshenko M, Vishneva E, Efendieva K, Namazova-Baranova L. The prevalence of allergic pathology in schoolchildren in the Russian Federation. Allergy. 2023;78(S111):573. https://doi.org/10.1111/all.15616

4. Matza LS, Paramore C, Prasad M. A review of the economic burden of ADHD. Cost Eff Resour Alloc. 2005;3:5. https://doi.org/10.1186/1478-7547-3-5

5. Karkashadze G, Maslova O, NamazovaBaranova L. Current Problems of Diagnosis and Treatment of Mild Cognitive Impairments in Children. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2011;8(5):37–41. (In Russ).

6. Calderón MA, Kleine-Tebbe J, Linneberg A, et al. House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies. J Allergy Clin Immunol Pract. 2015;3(6):843–855. https://doi.org/10.1016/j.jaip.2015.06.019

7. Bantz SK, Zhu Z, Zheng T. The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma. J Clin Cell Immunol. 2014;5(2):202. https://doi.org/10.4172/2155-9899.1000202

8. Spergel JM. Atopic march: link to upper airways. Curr Opin Allergy Clin Immunol. 2005;5(1):17–21. https://doi.org/10.1097/00130832-200502000-00005

9. Saunes M, Øien T, Dotterud CK, et al. Early eczema and the risk of childhood asthma: a prospective, population-based study. BMC Pediatr. 2012;12:168. https://doi.org/10.1186/1471-2431-12-168

10. Leynaert B, Neukirch C, Kony S, et al. Association between asthma and rhinitis according to atopic sensitization in a population-based study. J Allergy Clin Immunol. 2004;113(1):86–93. https://doi.org/10.1016/j.jaci.2003.10.010

11. Rowe AH. Аllergic toxemia and migraine due to food allergy: report of cases. Cal West Med. 1930;33(5):785–793. https://doi.org/10.1016/j.jaci.2003.10.010

12. Butler A, Van Lieshout RJ, Lipman EL, et al. Mental disorder in children with physical conditions: a pilot study. BMJ Open. 2018;8(1):e019011. https://doi.org/10.1136/bmjopen-2017-019011

13. Hammer-Helmich L, Linneberg A, Obel C, et al. Mental health associations with eczema, asthma and hay fever in children: a crosssectional survey. BMJ Open. 2016;6(10):e012637. https://doi.org/10.1136/bmjopen-2016-012637

14. Sztein DM, Lane WG. Examination of the comorbidity of mental illness and somatic conditions in hospitalized children in the United States using the kids’ inpatient database, 2009. Hospital Pediatr. 2016;6(3):126–134. https://doi.org/10.1542/hpeds.2015-0117

15. Ferro MA, Van Lieshout RJ, Scott JG, et al. Condition-specific associations of symptoms of depression and anxiety in adolescents and young adults with asthma and food allergy. J Asthma. 2016;53(3):282–288. https://doi.org/10.3109/02770903.2015.1104694

16. Karkashadze GA, Gogberashvili TY, Konstantinidi TA, et al. A single-stage population-based study of the prevalence of mild cognitive impairment in children of secondary school age. Annals of the Russian academy of medical sciences. 2023;78(4):329–347. (In Russ). https://doi.org/10.15690/vramn12460

17. Margari L, Buttiglione M, Craig F, et al. Neuropsychopathological comorbidities in learning disorders. BMC Neurol. 2013;13:198. https://doi.org/10.1186/1471-2377-13-198

18. Flapper BC, Schoemaker MM. Developmental coordination disorder in children with specific language impairment: comorbidity and impact on quality of life. Res Dev Disabil. 2013;34(2):756–763. https://doi.org/10.1016/j.ridd.2012.10.014

19. Tsui KW, Lai KY, Lee MM, et al. Prevalence of motor problems in children with attention deficit hyperactivity disorder in Hong Kong. Hong Kong Med J. 2016;22(2):98–105. https://doi.org/10.12809/hkmj154591

20. Tosto MG, Momi SK, Asherson P, et al. A systematic review of attention deficit hyperactivity disorder (ADHD) and mathematical ability: current findings and future implications. BMC Med. 2015;13:204. https://doi.org/10.1186/s12916-015-0414-4

21. Расстройства аутистического спектра: клинические рекомендации. Минздрав России; 2020. Доступно по: https://cr.minzdrav.gov.ru/schema/594_1. Ссылка активна на 20.03.2024.

22. Ustinova NV, Namazova-Baranova LS. Role of Pediatrician in Early Risk Evaluation, Diagnosis and Management of Children with Autism Spectrum Disorders. Voprosy sovremennoi pediatrii — Current Pediatrics. 2021;20(2):116–121. (In Russ). https://doi.org/10.15690/vsp.v20i2.2255]

23. Penninx BW, Pine DS, Holmes EA, Reif A. Anxiety disorders. Lancet. 2021;397(10277):914–927. https://doi.org/10.1016/S0140-6736(21)00359-7

24. Disorders Diagnostic and Statistical Manual of Mental Disorders. Washington, DC; London, England: American Psychiatric Association; 2013. 992 p. Available online: https://repository.poltekkes-kaltim.ac.id/657/1/Diagnostic%20and%20statistical%20manual%20of%20mental%20disorders%20_%20DSM-5%20%28%20PDFDrive.com%20%29.pdf. Accessed on June 03, 2024.

25. Turecki G, Brent DA. Suicide and suicidal behaviour. Lancet. 2016;387(10024):1227–1239. https://doi.org/10.1016/S0140-6736(15)00234-2

26. Schans JV, Çiçek R, de Vries TW, et al. Association of atopic diseases and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses. Neurosci Biobehav Rev. 2017;74(Pt A):139–148. https://doi.org/10.1016/j.neubiorev.2017.01.011

27. Miyazaki C, Koyama M, Ota E, et al. Allergic diseases in children with attention deficit hyperactivity disorder: a systematic review and meta-analysis. BMC Psychiatry. 2017;17(1):120. https://doi.org/10.1186/s12888-017-1281-7

28. Cortese S, Sun S, Zhang J, et al. Association between attention deficit hyperactivity disorder and asthma: a systematic review and meta-analysis and a Swedish population-based study. Lancet Psychiatry. 2018;5(9):717–726. https://doi.org/10.1016/S2215-0366(18)30224-4

29. Qu X, Lee LC, Ladd-Acosta C, et al. Association between atopic diseases and neurodevelopmental disabilities in a longitudinal birth cohort. Autism Res. 2022;15(4):740–750. https://doi.org/10.1002/aur.2680

30. Chuang YC, Wang CY, Huang WL, et al. Two meta-analyses of the association between atopic diseases and core symptoms of attention deficit hyperactivity disorder. Sci Rep. 2022;12(1):3377. https://doi.org/10.1038/s41598-022-07232-1

31. Strom MA, Silverberg JI. Asthma, hay fever, and food allergy are associated with caregiver-reported speech disorders in US children. Pediatr Allergy Immunol. 2016;27(6):604–611. https://doi.org/10.1111/pai.12580

32. Sommer M, Waltersbacher A, Schlotmann A, et al. Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data. Front Hum Neurosci. 2021;15:645292. https://doi.org/10.3389/fnhum.2021.645292

33. Ajdacic-Gross V, Bechtiger L, Rodgers S, et al. Subtypes of stuttering determined by latent class analysis in two Swiss epidemiological surveys. PLoS One. 2018;13(8):e0198450. https://doi.org/10.1371/journal.pone.0198450

34. Garg N, Silverberg JI. Association between childhood allergic disease, psychological comorbidity, and injury requiring medical attention. Ann Allergy Asthma Immunol. 2014;112(6):525–532. https://doi.org/10.1016/j.anai.2014.03.006

35. Tomilova A, Namazova-Baranova L, Kuzenkova L, Maslova O. Correction of Cognitive Disorders Among the Children with Allergic Rhinitis. Voprosy sovremennoi pediatrii — Current Pediatrics. 2007;6(2):123–127. (In Russ).

36. Muradova OI, Namazova-Baranova LS, Torshkhoeva RM, Karkashadze GA. The Influence of Pollinosis in Remission Stage on Cognitive Functions of Children. Voprosy diagnostiki v pediatrii. 2012;4(2):48–50. (In Russ).

37. Trikojat K, Buske-Kirschbaum A, Schmitt J, Plessow F. Altered performance in attention tasks in patients with seasonal allergic rhinitis: seasonal dependency and association with disease characteristics. Psychol Med. 2015;45(6):1289–1299. https://doi.org/10.1017/S0033291714002384

38. Chua RXY, Tay MJY, Ooi DSQ, et al. Understanding the Link Between Allergy and Neurodevelopmental Disorders: A Current Review of Factors and Mechanisms. Front Neurol. 2021;11:603571. https://doi.org/10.3389/fneur.2020.603571

39. Konstantinou GN, Konstantinou GN, Koulias C, et al. Further Understanding of Neuro-Immune Interactions in Allergy: Implications in Pathophysiology and Role in Disease Progression. J Asthma Allergy. 20220;15:1273–1291. https://doi.org/10.2147/JAA.S282039

40. Kim S, Kim H, Yim YS, et al Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring. Nature. 2017;549(7673):528–532. https://doi.org/10.1038/nature23910

41. Hadamitzky M, Lückemann L, Pacheco-López G, Schedlowski M. Pavlovian Conditioning of Immunological and Neuroendocrine Functions. Physiol Rev. 2020;100(1):357–405. https://doi.org/10.1152/physrev.00033.2018

42. Wilson SR, Thé L, Batia LM, et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell. 2013;155(2):285–295. https://doi.org/10.1016/j.cell.2013.08.057

43. Nutma E, Willison H, Martino G, Amor S. Neuroimmunology — the past, present and future. Clin Exp Immunol. 2019;197(3):278–293. https://doi.org/10.1111/cei.13279

44. Germundson DL, Nagamoto-Combs K. Potential Role of Intracranial Mast Cells in Neuroinflammation and Neuropathology Associated with Food Allergy. Cells. 2022;11(4):738. https://doi.org/10.3390/cells11040738

45. Brishti A, Germundson-Hermanson DL, Smith NA, et al. Asymptomatic sensitization to a cow’s milk protein induces sustained neuroinflammation and behavioral changes with chronic allergen exposure. Front Allergy. 2022;3:870628. https://doi.org/10.3389/falgy.2022.870628

46. Chang SJ, Kuo HC, Chou WJ, et al. Cytokine Levels and Neuropsychological Function among Patients with Attention-Deficit/Hyperactivity Disorder and Atopic Diseases. J Pers Med. 2022;12(7):1155. https://doi.org/10.3390/jpm12071155

47. Mogensen N, Larsson H, Lundholm C, Almqvist C. Association between childhood asthma and ADHD symptoms in adolescence-a prospective population-based twin study. Allergy. 2011;66(9):1224–1230. https://doi.org/10.1111/j.1398-9995.2011.02648.x

48. Instanes JT, Halmøy A, Engeland A, et al. Attention-deficit/hyperactivity disorder in offspring of mothers with inflammatory and immune system diseases. Biol Psychiatry. 2017;81:452–459. https://doi.org/10.1016/j.biopsych.2015.11.024

49. Fulton JF. Somatic functions of the central nervous system. Annu Rev Physiol. 1953;15:305–328. https://doi.org/10.1146/annurev.ph.15.030153.001513

50. Moriyama S, Brestoff JR, Flamar AL, et al. β(2)-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses. Science. 2018;359(6379):1056–1061. https://doi.org/10.1126/science.aan4829

51. Galle-Treger L, Suzuki Y, Patel N, et al. Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity. Nat Commun. 2016;7:13202. https://doi.org/10.1038/ncomms13202

52. Tomaki M, Ichinose M, Miura M, et al. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med. 1995;151(3 Pt 1):613–617. https://doi.org/10.1164/ajrc-cm.151.3.7533601

53. Lyall K, Van de Water J, Ashwood P, Hertz-Picciotto I. Asthma and allergies in children with autism spectrum disorders: Results from the CHARGE study. Autism Res. 2015;8(5):567–574. https://doi.org/10.1002/aur.1471

54. Kotey S, Ertel K, Whitcomb B. Co-occurrence of autism and asthma in a nationally-representative sample of children in the United States. J Autism Dev Disord. 2014;44(12):3083–3088. https://doi.org/10.1007/s10803-014-2174-y 237

55. Xu G, Snetselaar LG, Jing J, et al. Association of food allergy and other allergic conditions with autism spectrum disorder in children. JAMA Network Open. 2018;1(2):e180279. https://doi.org/10.1001/jamanetworkopen.2018.0279

56. Rodrigues J, Franco-Pego F, Sousa-Pinto B, et al. Anxiety and depression risk in patients with allergic rhinitis: a systematic review and meta-analysis. Rhinology. 2021;59(4):360–373. https://doi.org/10.4193/Rhin21.087

57. Edvinsson Sollander S, Fabian H, Sarkadi A, et al. Asthma and allergies correlate with mental health problems in preschool children. Acta Paediatr. 2021;110(5):1601–1609. https://doi.org/10.1111/apa.15709

58. Cho JK, Yang H, Park J, et al. Association between allergic rhinitis and despair, suicidal ideation, and suicide attempts in Korean adolescents: a nationally representative study of one million adolescents. Eur Rev Med Pharmacol Sci. 2023;27(19):9248–9256. https://doi.org/10.26355/eurrev_202310_33952

59. Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry. 1999;156(2):181–189. https://doi.org/10.1176/ajp.156.2.181

60. Postolache TT, Stiller JW, Herrell R, et al. Tree pollen peaksare associated with increased nonviolent suicide in women. Mol Psychiatry. 2005;10(3):232–235. https://doi.org/10.1038/sj.mp.4001620

61. Amritwar AU, Lowry CA, Brenner LA, et al. Mental Health in Allergic Rhinitis: Depression and Suicidal Behavior. Curr Treat Options Allergy. 2017;4(1):71–97. https://doi.org/10.1007/s40521-017-0110-z

62. Postolache TTM, Komarow HDM, Stiller JWM, Tonelli LHP. Allergy, Depression, and Suicide. Directions in Psychiatry. 2005;25:59–66.

63. Musselman DL, Miller AH, Porter MR, et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry. 2001;158(8):1252–1257. https://doi.org/10.1176/appi.ajp.158.8.1252

64. Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord. 2012;139(3):230–239. https://doi.org/10.1016/j.jad.2011.08.003

65. Bahrini L, Ouanes S, Ghachem R. Inflammatory profile in depression and associated clinical and sociodemographic features in a MiddleEastern North-African population. J Affect Disord. 2016;198:122–126. https://doi.org/10.1016/j.jad.2016.03.036

66. Levine J, Barak Y, Chengappa KN, et al. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology. 1999;40(4):171–176. https://doi.org/10.1159/000026615

67. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–457. https://doi.org/10.1016/j.biopsych.2009.09.033

68. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171–186. https://doi.org/10.1097/PSY.0b013e3181907c1b

69. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology. 2000;22(4):370–379. https://doi.org/10.1016/s0893-133x(99)00134-7

70. Eyre HA, Lavretsky H, Kartika J, et al. Modulatory Effects of Antidepressant Classes on the Innate and Adaptive Immune System in Depression. Pharmacopsychiatry. 2016;49(3):85–96. https://doi.org/10.1055/s-0042-103159

71. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24–31. https://doi.org/10.1016/j.it.2005.11.006

72. Postolache TT, Mortensen PB, Tonelli LH, et al. Seasonal spring peaks of suicide in victims with and without prior history of hospitalization for mood disorders. J Affect Disord. 2010;121(1–2):88–93. https://doi.org/10.1016/j.jad.2009.05.015

73. Coimbra DG, Pereira ESAC, de Sousa-Rodrigues CF, et al. Do suicide attempts occur more frequently in the spring too? A systematic review and rhythmic analysis. J Affect Disord. 2016;196:125–37. https://doi.org/10.1016/j.jad.2016.02.036

74. Timonen M, Viilo K, Hakko H, et al. Is seasonality of suicides stronger in victims with hospital-treated atopic disorders? Psychiatry Res. 2004;126(2):167–175. https://doi.org/10.1016/j.psychres.2004.02.005

75. Messias E, Clarke DE, Goodwin RD. Seasonal allergies and suicidality: results from the National Comorbidity Survey Replication. Acta Psychiatr Scand. 2010;122(2):139–142. https://doi.org/10.1111/j.1600-0447.2009.01518.x

76. Ross TM, Zuckermann RN, Reinhard C, Frey WH 2nd. Intranasal administration delivers peptoids to the rat central nervous system. Neurosci Lett. 2008;439(1):30–33. https://doi.org/10.1016/j.neulet.2008.04.097

77. Kalueff AV, Lehtimaki KA, Ylinen A, et al. Intranasal administration of human IL-6 increases the severity of chemically induced seizures in rats. Neurosci Lett. 2004;365(2):106–110. https://doi.org/10.1016/j.neulet.2004.04.061

78. Thorne RG, Pronk GJ, Padmanabhan V, Frey WH 2nd. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience. 2004;127(2):481–496. https://doi.org/10.1016/j.neuroscience.2004.05.029

79. Ross TM, Martinez PM, Renner JC, et al Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a noninvasive treatment strategy for multiple sclerosis. J Neuroimmunol. 2004;151(1–2):66–77. https://doi.org/10.1016/j.jneuroim.2004.02.011

80. Reichenberg A, Yirmiya R, Schuld A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry. 2001;58(5):445–452. https://doi.org/10.1001/archpsyc.58.5.445

81. Tonelli LH, Postolache TT. Airborne inflammatory factors: “from the nose to the brain”. Front Biosci (Schol Ed). 2010;2(1):135–152. https://doi.org/10.2741/s52

82. Pace TW, Hu F, Miller AH. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun. 2007;21(1):9–19. https://doi.org/10.1016/j.bbi.2006.08.009

83. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry. 2002;7(3):254–275. https://doi.org/10.1038/sj.mp.4001032

84. Scadding G. Cytokine profiles in allergic rhinitis. Curr Allergy Asthma Rep. 2014;14(5):435. https://doi.org/10.1007/s11882-014-0435-7

85. Bedolla-Barajas M, Morales-Romero J, Pulido-Guillen NA, et al. Rhinitis as an associated factor for anxiety and depression amongst adults. Braz J Otorhinolaryngol. 2017;83(4):432–438. https://doi.org/10.1016/j.bjorl.2016.05.008

86. Brundin L, Erhardt S, Bryleva EY, et al. The role of inflammation in suicidal behaviour. Acta Psychiatr Scand. 2015;132(3):192–203. https://doi.org/10.1111/acps.12458

87. Bay-Richter C, Linderholm KR, Lim CK, et al. A role for inflammatory metabolites as modulators of the glutamate N-methylD-aspartate receptor in depression and suicidality. Brain Behav Immun. 2015;43:110–117. https://doi.org/10.1016/j.bbi.2014.07.012

88. Oxenkrug G. Serotonin-kynurenine hypothesis of depression: historical overview and recent developments. Curr Drug Targets. 2013;14(5):514–521. https://doi.org/10.2174/1389450111314050002

89. Parrott JM, Redus L, O’Connor JC. Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge. J Neuroinflammation. 2016;13(1):124. https://doi.org/10.1186/s12974-016-0590-y

90. Maier SF. Bi-directional immune-brain communication: Implications for understanding stress, pain, and cognition. Brain Behav Immun. 2003;17(2):69–85. https://doi.org/10.1016/s0889-1591(03)00032-1

91. Woo JM, Gibbons RD, Qin P, et al. Suicide and prescription rates of intranasal corticosteroids and nonsedating antihistamines for allergic rhinitis: an ecological study. J Clin Psychiatry. 2011;72(10):1423–1438. https://doi.org/10.4088/JCP.10m06765

92. Brown ES, Chandler PA. Mood and Cognitive Changes During Systemic Corticosteroid Therapy. Prim Care Companion J Clin Psychiatry. 2001;3(1):17–21. https://doi.org/10.4088/pcc.v03n0104

93. Wallerstedt SM, Brunlöf G, Sundström A, Eriksson AL. Montelukast and psychiatric disorders in children. Pharmacoepidemiol Drug Saf. 2009;18(9):858–864. https://doi.org/10.1002/pds.1794

94. Fox CW, Khaw CL, Gerke AK, Lund BC. Montelukast and neuropsychiatric events — a sequence symmetry analysis. J Asthma. 2022;59(12):2360–2366. https://doi.org/10.1080/02770903.2021.2018705

95. Tel BC, Telli G, Onder S, et al. Investigation of the relationship between chronic montelukast treatment, asthma and depressionlike behavior in mice. Exp Ther Med. 2021;21(1):27. https://doi.org/10.3892/etm.2020.9459

96. Marques CF, Marques MM, Justino GC. The mechanisms underlying montelukast’s neuropsychiatric effects — new insights from a combined metabolic and multiomics approach. Life Sci. 2022;310:121056. https://doi.org/10.1016/j.lfs.2022.121056

97. Shin EY, Jin JH, Kang MK. Adverse drug reactions of montelukast and pranlukast: Analysis of the Korea database. Asian Pac J Allergy Immunol. 2022. https://doi.org/10.12932/AP-030821-1202

98. Lo CWH, Pathadka S, Qin SX, et al. Neuropsychiatric events associated with montelukast in patients with asthma: a systematic review. Eur Respir Rev. 2023;32(169):230079. https://doi.org/10.1183/16000617.0079-2023

99. Yu RL, Wang J, Wang XS, et al. Management of allergic rhinitis improves clinical outcomes of difficult-to-treat tic disorders or attention-deficit/hyperactivity disorders. Allergol Select. 2023;7:191–197. https://doi.org/10.5414/ALX400588E

100. Chung H, Hanken K, Gerke AK, Lund BC. Montelukast and risk for antidepressant treatment failure. J Psychosom Res. 2023;164:111075. https://doi.org/10.1016/j.jpsychores.2022.111075

101. Sansing-Foster V, Haug N, Mosholder A, et al. Risk of psychiatric adverse events among montelukast users. J Allergy Clin Immunol Pract. 2021;9(1):385–393.e12. https://doi.org/10.1016/j.jaip.2020.07.052

102. Paljarvi T, Forton J, Luciano S, et al. Analysis of neuropsychiatric diagnoses after montelukast initiation. JAMA Netw Open. 2022;5(5):e2213643. https://doi.org/10.1001/jamanetworkopen.2022.13643

103. Tonelli LH, Stiller J, Rujescu D, et al. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand. 2008;117(3):198–206. https://doi.org/10.1111/j.1600-0447.2007.01128.x

104. Tonelli LH, Katz M, Kovacsics CE, et al. Allergic rhinitis induces anxiety-like behavior and altered social interaction in rodents. Brain Behav Immun. 2009;23(6):784–793. https://doi.org/10.1016/j.bbi.2009.02.017

105. Basova AY, Bebchuk MA, Ustinova NV, et al. Pediatricians’ Competence in Prevention, Risk Determination or Detection of Suicidal Behavior in Children: Cross-Sectional Survey Study. Voprosy sovremennoi pediatrii — Current Pediatrics. 2021;20(3):234–241. (In Russ). https://doi.org/10.15690/vsp.v21i3.2430